ExploreWatchlistsPricing
  1. JP-listed companies
  2. HISAMITSU PHARMACEUTICAL CO.,INC.
  3. Financials
  4. Income before tax

HISAMITSU PHARMACEUTICAL CO.,INC. (4530)

Market cap
¥514.8B
P/E ratio
19.9x
Hisamitsu Pharmaceutical manufactures and sells over-the-counter medications like allergy treatments, operating globally through subsidiaries in the US, Europe, and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Feb 28, 202524,010+22.19%
Feb 29, 202419,649+22.42%
Feb 28, 202316,051+27.01%
Feb 28, 202212,638+6.84%
Feb 28, 202111,829-53.84%
Feb 29, 202025,628+3.98%
Feb 28, 201924,647-12.74%
Feb 28, 201828,245+0.23%
Feb 28, 201728,179+0.61%
Feb 29, 201628,008-1.69%
Feb 28, 201528,489-1.46%
Feb 28, 201428,910-12.53%
Feb 28, 201333,051-1.32%
Feb 29, 201233,494

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat